Burning Rock Biotech Ltd expected to post a loss of CNY1.50 a share - Earnings Preview

Burning Rock Biotech

21/05/2021 13:50

* Burning Rock Biotech Ltd  BNR.OQ   BNR.O  is expected
to report results on May 25.
* The Guangzhou, Guangdong-based company is expected to report
revenue of CNY125.9 million, according to the estimate from one
analyst, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for Burning Rock Biotech
Ltd is for a loss of CNY1.50 per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is CNY150.89​, about 75.2% above​ its last closing
price of $37.45. ​​​
* Previous quarterly performance (using preferred earnings
measure in Chinese yuan renminbi). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -1.24       -1.24      -1.51     Missed  -21.8
 Sep. 30 2020  -0.76       -0.76      -1.22     Missed  -60.7
 Jun. 30 2020  -1.40       -1.38      -2.69     Missed  -91.9​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated May 21 at 12:50 GMT.  All
figures in Chinese yuan renminbi unless otherwise stated